Depressive Disorder Clinical Trials Database - Free Access to 127 Studies
Access comprehensive clinical trial information for Depressive Disorder through Pure Global AI's free database. This collection includes 127 clinical trials across multiple phases including N/A, Phase 1, Phase 2. Currently, 21 trials are actively recruiting participants.
Research for Depressive Disorder is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include GlaxoSmithKline and Sanofi. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
M3VAS Validation in Polish Population
Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State
Feasibility of Integrated Care of Depression in Primary Care Pathways
Augmentation of Interpersonal Psychotherapy With High-Definition Transcranial Direct Current Stimulation for Adolescent Depression
Electroconvulsive Therapy and Concomitant Lithium in Depressive Disorder: A Pilot Study
Research on the Biological Mechanism of the Efficacy of Psychotherapy for Depression Based on the fNIRS
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
Depressed Mood Improvement Through Nicotine Dosing 3
Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension
Feasibility of Cognitive-Behavior Group Therapy for Depressive Disorders: Randomized Controlled Trial
Combining Antidepressants and Attention Bias Modification in Depression
Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
Effects of Ciprofol Anesthesia on Learning and Memory Function and Antidepressant Effects of ECT in Depressive Patients
Untitled Trial
A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of DGX-001
Establish a Specific Cohort Database for Depressive Disorders
PKPD of Oral vs IV S-Ketamine in HV
Untitled Trial
Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform
Pure Global AI provides free access to 127 clinical trials studying Depressive Disorder, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include GlaxoSmithKline, Sanofi, Shanghai Mental Health Center, among others.